… -endocrine tumors (dpNETs) are the most important disease-related cause of death in patients
with multiple endocrine neoplasia type 1 (MEN1). … highly prevalent in MEN1 and clinically …

… data in the Endocrine Surgery MEN1 database between 1993 and 2015. Patients included
in this study fulfilled clinical, genetic, and/or familial criteria for MEN1 syndrome based on …

… endocrine neoplasia 1 syndrome (MEN-1). As its main pathogenic factor involves genetic
mutations, it can cause a variety of different clinical symptoms. However, cases with negative …

… tumors (PETs): metastatic neuroendocrine carcinoma is the leading cause of disease-… the
mutations in the MEN1 gene and the associated neuroendocrine neoplasms. We identified a …

… However, one has to keep in mind that this strategy does only control but not cure pancreatic
disease in MEN1, since in the present study, 63% of patients developed new NF-pNENs in …

… endocrine neoplasia type 1 syndrome (MEN1) is a disease caused by mutations in the
MEN1 tumor … , pituitary adenomas, and entero-pancreatic neuroendocrine tumors. Pancreatic …

… Multiple endocrine neoplasia type 1 syndrome (MEN1) is a rare autosomal dominant familial
cancer syndrome affecting multiple endocrine glands. Published literature on MEN1 from …

… of the MEN1 gene in familial multiple endocrine neoplasia type 1 … disease in multiple
endocrine neoplasia type 1 (MEN 1): … disease in a large MEN 1 kindred. J Clin Endocrinol Metab …

… In patients with multiple endocrine neoplasia type 1 (MEN1), the most common functional
pancreatic endocrine tumor (PET) syndrome is Zollinger-Ellison syndrome (ZES). ZES has …

… was a trend toward increased positivity in MEN-1 syndrome patients. However, this was a …
5 MEN-1 syndrome patients would have been PTCH1 positive vs. 11 of 17 sporadic tumor …